Home > Insider Trading > Filing (0001209191-14-047905)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1432895	Joseph Wayne Riley	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-07-15	4,800	$33.89	5,000	No	4	M	Direct
Common Stock	Disposition	2014-07-15	2,492	$96.17	2,508	No	4	S	Direct
Common Stock	Disposition	2014-07-15	2,016	$97.02	492	No	4	S	Direct
Common Stock	Disposition	2014-07-15	292	$98.17	200	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2014-07-15	4,800	$0.00	4,800	$33.89

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
200		2020-07-08	No	4	M	Direct

Footnotes

Transaction made pursuant to Dr. Riley's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $96.17 (range $95.63 to $96.62).
Dr. Riley undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $97.02 (range $96.66 to $97.57).
Open market sales reported on this line occurred at a weighted average price of $98.17 (range $98.02 to $98.30).
Fully vested.